CRP and depressive symptom measurement: For instance, the MINDEP study selecting MDD patients with C-Reactive Protein (CRP)>1 mg/l showed a positive effect of minocycline augmentation on depression in post-hoc analyses for patients with elevated inflammation [CRP≥3 mg/l] (Nettis et al., 2021).